Clinical Trial Update: Transition to KPL-387 Monotherapy Dosing & Administration Study [Phase 2]

View source ↗

Summary

This document reports a Phase 2 transition to monotherapy dosing and administration for KPL-387. The trial is currently recruiting in patients with recurrent pe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Disease
• Pericarditis

Drugs mentioned

• KPL-387

Snippet

Sponsor: Kiniksa Pharmaceuticals International, plc | Conditions: Recurrent Pericarditis, Heart Diseases | Phase 2 | Status: RECRUITING